The Moderna vaccine and booster don't protect against Omicron as well as they do against the original SARS-CoV-2
oderna reported today the first data on how well its currently authorized vaccine and booster hold up against the
, which quickly dominated new infections around the world after health experts first described the variant last November. The company also announced that it is starting to study its Omicron-specific vaccine., the company’s scientists reported the results of a study involving blood samples from a small number of vaccinated participants.
A booster dose of the vaccine—which is half of one dose of the original shot—increased antibody levels in 20 study participants to 20 times higher than levels generated after the second dose of the vaccine, therefore restoring some of the waned protection. The scientists also tested a booster at the same dose as the primary two doses in another 20 volunteers, and that booster produced antibody levels that were at least two times higher than those generated by the half-dose booster.
Such rapid waning of protection after boosting with the existing vaccine makes a strong case for potentially boosting with an Omicron-specific shot, which the company is studying. That trial will include 300 people in 24 sites across the U.S. Moderna’s scientists are also evaluating combination vaccines, in which they put together vaccines developed for different variants, including one that targets the original virus and one that targets Omicron.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Moderna begins testing omicron-specific COVID-19 vaccine in adultsIt’s not clear whether global health authorities will order a change to the vaccine recipe in the wake of the hugely contagious omicron variant, since the original vaccines still offer good protection.
Weiterlesen »
Moderna starts clinical trial of booster shot targeting omicron Covid variantThe first participant in the trial has already received a dose of the omicron-specific booster shot, according to Moderna.
Weiterlesen »
Moderna begins next phase of Omicron-specific booster trial as study finds that antibodies remain durable despite 6-fold drop over 6 monthsModerna has announced that the first participant has been dosed in the company's Phase 2 clinical trial of a coronavirus vaccine booster shot that is specific to the Omicron variant
Weiterlesen »
In a joint letter, six unions from across county sectors say booster mandate will harm staffing“Santa Clara County led the way responding to Covid, and we have done very well,” the letter states. “With these latest changes though, we’re cutting off our nose to spite our fac…
Weiterlesen »
Pepsi Faces Boycott Threat Over Donation to Texas GOPPepsi is facing growing boycott calls over a $15,000 donation to the Texas Republican Party that appeared in state records three months after the state’s extreme restrictions on abortion went into effect.
Weiterlesen »
‘Stop panic selling’ — Bitcoin whales bag spare BTC as exchange balances fallBitcoin may be at multi-month lows, but buyer demand for BTC remains, data shows.
Weiterlesen »